全文获取类型
收费全文 | 148391篇 |
免费 | 11372篇 |
国内免费 | 4193篇 |
专业分类
耳鼻咽喉 | 1030篇 |
儿科学 | 3776篇 |
妇产科学 | 2495篇 |
基础医学 | 8401篇 |
口腔科学 | 2957篇 |
临床医学 | 18665篇 |
内科学 | 25989篇 |
皮肤病学 | 2400篇 |
神经病学 | 7042篇 |
特种医学 | 4331篇 |
外国民族医学 | 40篇 |
外科学 | 13870篇 |
综合类 | 21194篇 |
现状与发展 | 27篇 |
一般理论 | 4篇 |
预防医学 | 7136篇 |
眼科学 | 2122篇 |
药学 | 12628篇 |
95篇 | |
中国医学 | 11942篇 |
肿瘤学 | 17812篇 |
出版年
2024年 | 397篇 |
2023年 | 2758篇 |
2022年 | 4819篇 |
2021年 | 6495篇 |
2020年 | 6054篇 |
2019年 | 5466篇 |
2018年 | 5221篇 |
2017年 | 5665篇 |
2016年 | 5942篇 |
2015年 | 5698篇 |
2014年 | 10245篇 |
2013年 | 13194篇 |
2012年 | 8523篇 |
2011年 | 9098篇 |
2010年 | 7483篇 |
2009年 | 6943篇 |
2008年 | 6873篇 |
2007年 | 7277篇 |
2006年 | 6430篇 |
2005年 | 5736篇 |
2004年 | 4774篇 |
2003年 | 4313篇 |
2002年 | 3474篇 |
2001年 | 3112篇 |
2000年 | 2623篇 |
1999年 | 2065篇 |
1998年 | 1723篇 |
1997年 | 1492篇 |
1996年 | 1221篇 |
1995年 | 1090篇 |
1994年 | 902篇 |
1993年 | 715篇 |
1992年 | 642篇 |
1991年 | 587篇 |
1990年 | 478篇 |
1989年 | 447篇 |
1988年 | 435篇 |
1987年 | 395篇 |
1986年 | 323篇 |
1985年 | 396篇 |
1984年 | 355篇 |
1983年 | 242篇 |
1982年 | 284篇 |
1981年 | 269篇 |
1980年 | 252篇 |
1979年 | 226篇 |
1978年 | 146篇 |
1977年 | 117篇 |
1976年 | 114篇 |
1973年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Sharon Leighton 《Journal of child and adolescent psychiatric nursing》2008,21(1):24-34
TOPIC: Bereavement therapy as a catalyst for spiritual growth. PURPOSE: This study aims to review the literature and reflect on the bereavement therapy undertaken with two adolescents who had been bereaved during childhood. SOURCES: Research articles and books identified through a combination of electronic and manual searches. CONCLUSIONS: It would appear that grief therapy could facilitate spiritual growth in such circumstances. Further in-depth studies are required to identify how typical or atypical this experience is, and to contribute to the evidence base for working with bereaved children and adolescents. 相似文献
62.
63.
目的 观察急性大血管闭塞性轻型卒中患者血管内治疗的疗效及安全性。
方法 回顾性分析2018年1月-2019年5月行血管内治疗的急性大血管闭塞性轻型卒中(NIHSS评分
≤5分)患者的临床资料。观察术后血管成功再通率(mTICI≥2b级)、围手术期并发症、90 d良好预后率
(mRS评分≤2分)等。
结果 共纳入13例患者,平均年龄58.7±14.5岁,男性11例(84.6%)。术后血管成功再通率100%;围
手术期并发症2例,假性动脉瘤1例、无症状性颅内出血1例;90 d良好预后率100%。
结论 急性大血管闭塞性轻型卒中行血管内治疗可能是安全、有效的。 相似文献
64.
Medial epicondylitis is a chronic noninflammatory condition resulting from mechanical injury. Despite many treatment options,
including rest, medications, physiotherapy and operative interventions, the results are too often poor; thus new treatment
options are sought. We treated 4 men with chronic epicondylitis (5 affected joints) with extracorporeal shock wave therapy
after failed attempts of other treatments. The patients’ complaints were graded with the Nirschl scoring system prior to and
six months after therapy. The treatment consisted of three sessions, at 20-day intervals, of 3000 pulses of ultrasonic shock
waves from a Piezolith 3000 unit (energy dosage was gradually increased to reach step 10 equaling 0.9 mJ/mm2). At the 6-month follow-up, no patient was pain free. Three cases had slightly lower Nirschl scores than prior to the procedure
but the patients rated this difference as insignificant; two cases were unchanged. No complications were observed but all
patients rated the procedure as very unpleasant. The well recognized biologic effects of ultrasonographic waves (heat generation,
oscillations, cavitation, etc.) that result in functional and structural changes of cellular membranes with sonochemical reactions
(acceleration of normal metabolism, oxygenation and reduction in water solutions, polymer degradation, etc.), even if present
in our cases, did not result in a noticeable decrease of symptoms, even though we used high energy and more impulses per session.
Significant variations in methodology make inconclusive the results of numerous reports on the use of extracorporeal shock
waves in epicondylar degenerative problems, although ineffectiveness of such therapy is the conclusion of a review by Haake
and colleagues. 相似文献
65.
目的观察半乳糖化白蛋白磁性阿霉素纳米粒(ADR-GHMN)在正常肝脏中的靶向性,并观察ADR-GHMN在全身各脏器的分布特征及外加磁场对其分布的影响.方法大鼠正中开腹,肝动脉插管并固定,肝动脉注射125I-ADR-GHMN(相当于阿霉素0.5 mg/kg),左外叶加磁场,磁场应用30 min,移去磁场后,动物立即处死;对照组:肝动脉注射ADR-GHMN,左外叶不加磁场,30min后,移去磁场后,动物立即处死,立即取靶区肝、非靶区肝、肾、心、肺、小肠、脾及周围血作γ计数.肝组织作病理切片.结果注入的纳米粒75~85%分布于肝脏,其它脏器极少.病理切片显示磁区小动脉见大量纳米粒存在,对照组及非磁区肝中纳米粒很少见.结论ADR-GHMN在正常肝组织中有明显的磁靶向性;在磁场作用下,ADR-GHMN主要分布于肝脏,其它脏器含量很少;试验组肾、心、肺、小肠、脾及外周血于对照组的放射活性比较明显降低,表明磁性物质的存在使这些脏器的相对药物暴露明显减少. 相似文献
66.
Venous and arterial thrombosis are closely related to many severe diseases, especially to cardiovascular and cerebrovasular disorders. Thrombolytic therapy has been proven to be an effective method to treat such disease, which decreased the mortality and morbidity greatly. 相似文献
67.
阿米替林合并认知疗法治疗精神分裂症后抑郁的对照研究 总被引:4,自引:0,他引:4
目的 评价阿米替林合并认知疗法对精神分裂症后抑郁的治疗效果。方法 将符合CCMD 3诊断标准的 86例精神分裂症后抑郁患者随机分为治疗组和对照组 ,治疗组给予阿米替林合并认知治疗 ,对照组织给予阿米替林治疗 ,疗程 12周。采用汉密尔顿抑郁量表 (HAMD)、简明精神病量表(BPRS)、阴性症状量表 (SANS)评定临床疗效 ,采用副反应量表 (TESS)评定副反应。结果 在治疗的 4、8、12周末 ,HAMD评分治疗组优于对照组 ,显效率分别为 83 95 %和 6 1 90 % (u =5 .83,P <0 0 5 )。结论 阿米替林与认知治疗组结合治疗精神分裂症后抑郁疗效好于单用阿米替林治疗。 相似文献
68.
Paul Roderick Ruth Davies Chris Jones Terry Feest Steve Smith Ken Farrington 《Nephrology, dialysis, transplantation》2004,19(3):692-701
BACKGROUND: The demand for renal replacement therapy (RRT) in England has risen steadily, although from a lower base than many other developed countries. Predicting the future demand for RRT and the impact of factors such as the acceptance rate, transplant supply and patient survival, is required in order to inform the planning of such services. METHODS: A discrete event simulation model estimates the future demand for RRT in England in 2010 for a range of scenarios. The model uses current prevalence and current and projected future acceptance rates, survival rates and the transitions between modalities to predict future patient numbers. National population and mortality data, published literature and data from the UK Renal Registry and UK Transplant, are used to estimate unmet need for RRT, the impact of changing demography and incidence of Type 2 diabetes, patient haemodialysis (HD) survival and transplant supply. RESULTS: By 2010 the predicted prevalence will have increased from about 30,000 in 2000 to between 42 and 51,000 (900-1000 p.m.p.), an average annual growth of 4.5-6%. Changing transplant supply has a small effect on overall numbers but changes the proportion of patients with functioning graft by up to 8%. Even with an optimistic increase in transplant supply (11% p.a. for 5 years), numbers on HD will continue to rise substantially, especially in the elderly. The factors most influencing future patient numbers are the acceptance rate and dialysis survival. CONCLUSION: This model predicts a substantial growth in the RRT population to 2010 to a rate approaching 1000 p.m.p., particularly in the elderly and those on HD, with a steady state not being reached for at least 25 years. 相似文献
69.
Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer 总被引:2,自引:0,他引:2
MIZUKI ONOZAWA KOJI KAWAI TAKAHIRO YAMAMOTO SHIRO HINOTSU SADAMU TSUKAMOTO KAZUNORI HATTORI NAOTO MIYANAGA TORU SHIMAZUI HIDEYUKI AKAZA 《International journal of urology》2004,11(7):535-541
BACKGROUND: Since the advent of cisplatin-based chemotherapy, the majority of metastatic testicular cancers can be cured by chemotherapy followed by retroperitoneal lymph node dissection (RPLND). However, postchemotherapy RPLND confers no therapeutic benefit if the residual mass contains no viable cells. Therefore, to determine which parameters predict a patient's likelihood of having only necrosis in the residual mass, we retrospectively analyzed clinical parameters of patients who underwent postchemotherapy RPLND. METHODS: Data from 27 patients with metastatic testicular cancer were analyzed. The histology of the primary tumor was seminoma in 11 cases and non-seminoma in 16 cases. All of the patients with non-seminoma showed a normalization of tumor markers after chemotherapy. Analysis of clinical parameters included data for the initial histology, pretreatment tumor marker levels, postchemotherapy retroperitoneal mass size, and the histology of the dissected RPLNs. RESULTS: Histological examination of dissected RPLNs showed residual tumor in 27% of seminoma patients and 38% of non-seminoma patients. In seminoma patients, no viable cells were found in all six patients with pretreatment lactate dehydrogenase (LDH) levels below 7.5 times the upper limit of normal, or in all five of the patients with postchemotherapy RPLNs less than 2.5 cm. In non-seminoma patients, no viable cells were found in nine of 10 patients with pretreatment alpha-fetoprotein (AFP) levels less than 2700 ng/mL, or in eight of nine patients with residual mass less than 2.5 cm. CONCLUSIONS: Both postchemotherapy RPLN mass size and pretreatment tumor marker levels are possible predictors for necrosis of the residual mass in testicular cancer patients. 相似文献